Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2

Myocardial ischemia-reperfusion (I/R) injury remains the leading risk factor of disability and mortality worldwide. In this study, the myocardial protective effect of eriodictyol (EDT) and the underlying mechanism in an ex vivo model of global myocardial I/R was investigated. After treatment with di...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Li, Defang, Lu, Ning, Han, Jichun, Chen, Xiaoyu, Hao, Wenjin, Xu, Wenjuan, Liu, Xiaona, Ye, Lei, Zheng, Qiusheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2018
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5797583/
https://ncbi.nlm.nih.gov/pubmed/29441020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00033
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky